Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 4 Breast Neoplasms 4 Head and Neck Neoplasms 2 Fatigue 2 Uterine Cervical Neoplasms 1 Trismus 1 Sarcoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Lymphedema 1 Esophageal Neoplasms 1 Carcinoma, Bronchogenic 1 Brain Neoplasms 1 Agnosia 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Exercise Therapy × Clear all

NCT04877860 2023-05-09

PaiNEd

Universidad de Granada

Phase NA Unknown

Agnosia, Breast Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡